Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Health Catalyst (HCAT) EBIAT (2018 - 2026)

Health Catalyst filings provide 9 years of EBIAT readings, the most recent being -$111.0 million for Q1 2026.

  • On a quarterly basis, EBIAT fell 367.64% to -$111.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$265.3 million, a 265.08% decrease, with the full-year FY2025 number at -$178.0 million, down 156.07% from a year prior.
  • EBIAT hit -$111.0 million in Q1 2026 for Health Catalyst, down from -$91.0 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$13.5 million in Q2 2024 to a low of -$111.0 million in Q1 2026.
  • Median EBIAT over the past 5 years was -$30.3 million (2023), compared with a mean of -$36.1 million.
  • Biggest five-year swings in EBIAT: soared 58.56% in 2024 and later tumbled 367.64% in 2026.
  • Health Catalyst's EBIAT stood at -$35.8 million in 2022, then grew by 15.29% to -$30.3 million in 2023, then soared by 31.8% to -$20.7 million in 2024, then plummeted by 340.31% to -$91.0 million in 2025, then decreased by 21.97% to -$111.0 million in 2026.
  • The last three reported values for EBIAT were -$111.0 million (Q1 2026), -$91.0 million (Q4 2025), and -$22.2 million (Q3 2025) per Business Quant data.